Lupin Launches Formoflo-G MDI, World''s First Fixed-dose Triple Combination Drug for COPD Management.
Exchange summary
EarningsCanvas
Loading your research…
Opening the latest published company and exchange records.
EarningsCanvas
Opening the latest published company and exchange records.
NSE · NSE SME · BSE
Results, orders and company updates, with a trail back to the filing. Check the feed status below for freshness.
Exchange intelligence
The collection is overdue. These are last known disclosures. Check the official exchange for newer announcements.
Lupin Launches Formoflo-G MDI, World''s First Fixed-dose Triple Combination Drug for COPD Management.
Multicare Pharmaceuticals Philippines, Inc. (MPPI) has completed buyback of 30,559 shares, pursuant to which MPPI has become a step-down wholly owned subsidiary of the Company effective from October 01, 2026.